Weight loss outcomes while taking semaglutide GLP-1 can vary significantly from case to case based on individual factors such as your diet routines, exercise habits, metabolism, and overall health
This does not mean that every side effect is related to expiration
Nsc-617593 90
argues that intensive weight loss can create a POPdriven toxic rebound that partially undermines cardiometabolic benefits and may promote weight regain by mobilizing lipophilic pollutants from adipose into blood and target organs.3 From this publication, we learn that the abrupt rise in circulating POPs during intensive weight loss can: Disturb energy metabolism (resting metabolic rate/sleeping metabolic rate), oxidative enzymes, thyroid axis) Impair insulin action and mitochondrial function Redistribute POPs from adipose to organs (liver, muscle, pancreas, nervous system), increasing cardiometabolic risk The authors summarize clinical data where intentional weight loss improves body weight and some risk factors, but does not fully normalize, or even worsens glucose tolerance, blood lipids, or inflammatory markers
Gastrectomy, in which a portion or all of your stomach is removed
